Circulating metabolomic and lipidomic changes in subjects with new-onset type 1 diabetes after optimization of glycemic control.

[1]  C. Mathieu,et al.  Type 1 diabetes glycemic management: Insulin therapy, glucose monitoring, and automation , 2021, Science.

[2]  M. Bermudez-lopez,et al.  Outstanding improvement of the advanced lipoprotein profile in subjects with new-onset type 1 diabetes mellitus after achieving optimal glycemic control. , 2021, Diabetes research and clinical practice.

[3]  L. Cowart,et al.  Sphingolipids in the Heart: From Cradle to Grave , 2020, Frontiers in Endocrinology.

[4]  T. Suvitaival.  Lipidomic Abnormalities During the Pathogenesis of Type 1 Diabetes: a Quantitative Review , 2020, Current Diabetes Reports.

[5]  G. Lewis,et al.  Glycemia and Atherosclerotic Cardiovascular Disease: Exploring the Gap Between Risk Marker and Risk Factor , 2020, Frontiers in Cardiovascular Medicine.

[6]  B. Vergès.  Dyslipidemia in Type 1 Diabetes: A Masked Danger , 2020, Trends in Endocrinology & Metabolism.

[7]  P. Fort,et al.  New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism , 2019, Diabetologia.

[8]  Shiful Islam,et al.  Assessment of the relationship between serum uric acid and glucose levels in healthy, prediabetic and diabetic individuals , 2019, Diabetology & Metabolic Syndrome.

[9]  D. Prakoso,et al.  Lipid metabolism and its implications for type 1 diabetes-associated cardiomyopathy. , 2017, Journal of molecular endocrinology.

[10]  Hyungwon Choi,et al.  Plasma Metabonomic Profiling of Diabetic Retinopathy , 2016, Diabetes.

[11]  Xianlin Han,et al.  Novel advances in shotgun lipidomics for biology and medicine. , 2016, Progress in lipid research.

[12]  Steffen Neumann,et al.  IPO: a tool for automated optimization of XCMS parameters , 2015, BMC Bioinformatics.

[13]  Tuulia Hyötyläinen,et al.  Optimizing the lipidomics workflow for clinical studies—practical considerations , 2015, Analytical and Bioanalytical Chemistry.

[14]  B. Perkins,et al.  Developmental Origins of Health and Disease Glycosuria-mediated urinary uric acid excretion in patients with uncomplicated type 1 diabetes mellitus , 2014 .

[15]  L. Dimeglio,et al.  Established and emerging biomarkers for the prediction of type 1 diabetes: a systematic review. , 2014, Translational research : the journal of laboratory and clinical medicine.

[16]  Ji Miao,et al.  Hepatic insulin receptor deficiency impairs the SREBP-2 response to feeding and statins[S] , 2014, Journal of Lipid Research.

[17]  W. Kerner,et al.  Definition, classification and diagnosis of diabetes mellitus. , 2014, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[18]  B. Miller,et al.  Lipidomic analysis of human plasma reveals ether-linked lipids that are elevated in morbidly obese humans compared to lean , 2013, Diabetology & Metabolic Syndrome.

[19]  Natalie I. Tasman,et al.  A Cross-platform Toolkit for Mass Spectrometry and Proteomics , 2012, Nature Biotechnology.

[20]  S. Zeisel.  Dietary choline deficiency causes DNA strand breaks and alters epigenetic marks on DNA and histones. , 2012, Mutation research.

[21]  M. Peppelenbosch,et al.  A Phospholipidomic Analysis of All Defined Human Plasma Lipoproteins , 2011, Scientific reports.

[22]  A. Shankar,et al.  Association between Serum Uric Acid Levels and Diabetes Mellitus , 2011, International journal of endocrinology.

[23]  M. Eriksson,et al.  Circulating Proprotein Convertase Subtilisin Kexin Type 9 Has a Diurnal Rhythm Synchronous With Cholesterol Synthesis and Is Reduced by Fasting in Humans , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[24]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[25]  S. McCall,et al.  Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis , 2007, Hepatology.

[26]  M. Laville,et al.  Insulin activates human sterol-regulatory-element-binding protein-1c (SREBP-1c) promoter through SRE motifs. , 2006, The Biochemical journal.

[27]  H. Senn,et al.  Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics. , 2006, Analytical chemistry.

[28]  R. Abagyan,et al.  XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. , 2006, Analytical chemistry.

[29]  F. Foufelle,et al.  SREBP transcription factors: master regulators of lipid homeostasis. , 2004, Biochimie.

[30]  L. E. Hammond,et al.  Mitochondrial Glycerol-3-Phosphate Acyltransferase-Deficient Mice Have Reduced Weight and Liver Triacylglycerol Content and Altered Glycerolipid Fatty Acid Composition , 2002, Molecular and Cellular Biology.

[31]  T. M. Lewin,et al.  Regulation of mitochondrial sn-glycerol-3-phosphate acyltransferase activity: response to feeding status is unique in various rat tissues and is discordant with protein expression. , 2001, Archives of biochemistry and biophysics.

[32]  M. Foretz,et al.  Insulin effects on sterol regulatory-element-binding protein-1c (SREBP-1c) transcriptional activity in rat hepatocytes. , 2000, The Biochemical journal.

[33]  T. M. Lewin,et al.  Physiological and nutritional regulation of enzymes of triacylglycerol synthesis. , 2000, Annual review of nutrition.

[34]  I. Shimomura,et al.  Sterol regulatory element-binding proteins: activators of cholesterol and fatty acid biosynthesis. , 1999, Current opinion in lipidology.

[35]  J. Paulauskis,et al.  Transcriptional regulation of p90 with sequence homology to Escherichia coli glycerol-3-phosphate acyltransferase. , 1991, The Journal of biological chemistry.

[36]  M. Taskinen.  Lipoprotein lipase in diabetes. , 1987, Diabetes/metabolism reviews.

[37]  A. Bach,et al.  Medium-chain triglycerides: an update. , 1982, The American journal of clinical nutrition.